Jco low dose tamoxifen

22. Jun 10, 2023 · Purpose: Five-year data of the phase III trial TAM-01 showed that low-dose tamoxifen at 5 mg once daily administered for 3 years in women with intraepithelial neoplasia (IEN) reduced by 52% the recurrence of invasive breast cancer or ductal carcinoma in situ (DCIS), without additional adverse events over placebo

2024-03-29
    Buy tamoxifen citrate australia
  1. Mammographic density change is a proxy for tamoxifen therapy response
  2. 88; P =
  3. 1200/JCO
  4. 00656
  5. 97
  6. 7 (range, 8
  7. Journal of Clinical Oncology
  8. 11
  9. , Puntoni, M
  10. JCO 41 , 3116-3121 (2023)
  11. 97
  12. 9743 Journal of Clinical
  13. Local
  14. 19
  15. Fabian said
  16. Quick